Supporting Evidence in Phase 2 Cancer Trial Protocols: A Content Analysis.

Background: Phase 2 trials are instrumental for designing definitive efficacy trials or attaining accelerated approval. However, high attrition of drug candidates in phase 2 raises questions about their supporting evidence.

Methods: We developed a typology of supporting evidence for phase 2 cancer trials.